Symptomtext
16 month old was given 2 doses of Hib, given Acthib when he already got a dose of Pentacel with no reported adverse event; Initial information was received on 16-May-2022 regarding an unsolicited valid non-serious case received from a health care professional via call center. This case involves a 16 months old male patient who experienced 16 month old was given 2 doses of hib, given acthib when he already got a dose of pentacel with no reported adverse event while receiving vaccine HIB (PRP/T) vaccine [ACT-HIB]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included prevnar and pentacel for Prophylactic vaccination. On 16-May-2022, the patient received 0.5 ml of suspect HIB (PRP/T) vaccine (lot UJ521AA and expiry- 22-JUL-2023 ) (strength and formulation: unknown) via intramuscular route in the left upper thigh for immunization. On 16-MAY-2022 the patient developed a non-serious 16 month old was given 2 doses of hib, given acthib when he already got a dose of pentacel with no reported adverse event (extra dose administered) (latency same day) following the administration of HIB (PRP/T) vaccine. Action taken: not applicable. At time of reporting, the outcome was Unknown for the event 16 month old was given 2 doses of hib, given acthib when he already got a dose of pentacel with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.